SHSE:688253 (China)
Â
Class A
Â¥
43.81
(+4.91%)
Nov 29
Business Description
Innovita Biological Technology Co Ltd
ISIN : CNE100005Q14
Share Class Description:
SHSE:688253: Class ACompare
Compare
Traded in other countries / regions
688253.China IPO Date
2022-07-28Description
Innovita Biological Technology Co Ltd is a biotechnology company focusing on the research and development, production and sales of POCT in vitro diagnostic products.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 878.2 | |||||
| Equity-to-Asset | 0.94 | |||||
| Debt-to-EBITDA | 0.01 | |||||
| Interest Coverage | 2944.75 | |||||
| Piotroski F-Score | 7/9 | |||||
| Altman Z-Score | 30.96 | |||||
| Beneish M-Score | -2.72 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -30.5 | |||||
| 3-Year EBITDA Growth Rate | -37.9 | |||||
| 3-Year EPS without NRI Growth Rate | -42.8 | |||||
| 3-Year FCF Growth Rate | -32 | |||||
| 3-Year Book Growth Rate | 27.4 | |||||
| Future 3-5Y EPS without NRI Growth Rate | 60.17 | |||||
| Future 3-5Y Total Revenue Growth Rate | 39.28 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 66.41 | |||||
| 9-Day RSI | 58.59 | |||||
| 14-Day RSI | 56.03 | |||||
| 6-1 Month Momentum % | 2.79 | |||||
| 12-1 Month Momentum % | 38.37 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 16.39 | |||||
| Quick Ratio | 16.01 | |||||
| Cash Ratio | 15.48 | |||||
| Days Inventory | 140.65 | |||||
| Days Sales Outstanding | 41.05 | |||||
| Days Payable | 142.38 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 0.96 | |||||
| Dividend Payout Ratio | 0.15 | |||||
| Forward Dividend Yield % | 0.96 | |||||
| 5-Year Yield-on-Cost % | 0.96 | |||||
| 3-Year Average Share Buyback Ratio | -10.1 | |||||
| Shareholder Yield % | 1.01 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 81.27 | |||||
| Operating Margin % | 53.14 | |||||
| Net Margin % | 46.09 | |||||
| FCF Margin % | 56.38 | |||||
| ROE % | 17.25 | |||||
| ROA % | 15.98 | |||||
| ROIC % | 124.44 | |||||
| ROC (Joel Greenblatt) % | 285.48 | |||||
| ROCE % | 19.74 | |||||
| Years of Profitability over Past 10-Year | 6 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 18.1 | |||||
| Forward PE Ratio | 11.75 | |||||
| PE Ratio without NRI | 16.87 | |||||
| PS Ratio | 8.36 | |||||
| PB Ratio | 2.94 | |||||
| Price-to-Tangible-Book | 2.93 | |||||
| Price-to-Free-Cash-Flow | 14.86 | |||||
| Price-to-Operating-Cash-Flow | 13.96 | |||||
| EV-to-EBIT | 10.06 | |||||
| EV-to-EBITDA | 10.06 | |||||
| EV-to-Revenue | 5.33 | |||||
| EV-to-FCF | 9.45 | |||||
| Price-to-Graham-Number | 1.48 | |||||
| Price-to-Net-Current-Asset-Value | 3.24 | |||||
| Price-to-Net-Cash | 3.44 | |||||
| Earnings Yield (Greenblatt) % | 9.94 | |||||
| FCF Yield % | 6.77 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Innovita Biological Technology Co Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 720.403 | ||
| EPS (TTM) (Â¥) | 2.43 | ||
| Beta | 0 | ||
| Volatility % | 67.95 | ||
| 14-Day RSI | 56.03 | ||
| 14-Day ATR (Â¥) | 2.060901 | ||
| 20-Day SMA (Â¥) | 42.5705 | ||
| 12-1 Month Momentum % | 38.37 | ||
| 52-Week Range (Â¥) | 23.61 - 52.69 | ||
| Shares Outstanding (Mil) | 136.46 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 7 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Innovita Biological Technology Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Innovita Biological Technology Co Ltd Stock Events
| Event | Date | Price(Â¥) | ||
|---|---|---|---|---|
| No Event Data | ||||
Innovita Biological Technology Co Ltd Frequently Asked Questions
What is Innovita Biological Technology Co Ltd(SHSE:688253)'s stock price today?
The current price of SHSE:688253 is ¥43.81. The 52 week high of SHSE:688253 is ¥52.69 and 52 week low is ¥23.61.
When is next earnings date of Innovita Biological Technology Co Ltd(SHSE:688253)?
The next earnings date of Innovita Biological Technology Co Ltd(SHSE:688253) is .
Does Innovita Biological Technology Co Ltd(SHSE:688253) pay dividends? If so, how much?
The Dividend Yield %  of Innovita Biological Technology Co Ltd(SHSE:688253) is 0.96% (As of Today), Highest Dividend Payout Ratio of Innovita Biological Technology Co Ltd(SHSE:688253) was 0.15. The lowest was 0.15. And the median was 0.15. The  Forward Dividend Yield % of Innovita Biological Technology Co Ltd(SHSE:688253) is 0.96%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers